Skip to content

King Pharmaceuticals KG Commercial Auto Liability — Year 9

Other product segments

European Hospital Liability
4.9%
General Liability
3.8%
International
-0.7%
All other lines
-0.4%

Similar metrics at other companies

CNA Financial logo
CNACommercial Auto — Year 9
0.7%+0.2pp
United Fire Group logo
UFCSCommercial automobile — Year 9
0.5%+0.3pp
Old Republic International logo
ORICommercial Automobile — Year 9
0.3%-0.2pp
Old Republic International logo
ORICommercial Automobile — Year 10
0.3%+0.1pp
United Fire Group logo
UFCSCommercial other liability — Year 9
4.4%-0.3pp
CNA Financial logo
CNACommercial Auto — Year 10
0%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearNine.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's commercial auto liability — year 9.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's commercial auto liability — year 9?
King Pharmaceuticals (KG) reported commercial auto liability — year 9 of 1.6% in Q4 2025.
What does commercial auto liability — year 9 mean?
This metric captures the financial output of the commercial auto liability insurance segment in the ninth year. It highlights the company's competitive standing and revenue generation capacity within the commercial auto insurance landscape. Investors utilize this metric to evaluate the segment's resilience and its role in the company's broader insurance strategy.